Makoto Kodaira
Toda, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 09, 2023
Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication.
Journal: Diabetology international
Published: August 31, 2023
Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Journal: Medical oncology (Northwood, London, England)
Published: March 26, 2019
The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site.
Journal: Internal medicine (Tokyo, Japan)
Published: February 05, 2019
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.
Journal: Cancer science
Published: January 16, 2018
A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin.
Journal: Anti-cancer drugs
Published: November 28, 2017
The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 18, 2017
Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 24, 2017
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.
Journal: BMC cancer
Published: April 02, 2017
Last Updated: 09/26/2026